Quality of Life of Cypriot Patients Suffering with Huntington's Disease

Eleni Varda1, Christiana A Demetriou2, Alexandros Heraclides3

  • 1The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Plos Currents
|December 6, 2016
PubMed

Insights

Quality of life in Huntington

Area of Science:

  • Neurology
  • Quality of Life Research
  • Genetic Disorders

Background:

  • Huntington's disease (HD) presents significant motor, behavioral, and cognitive challenges, profoundly impacting patient and family quality of life (QoL).
  • Limited research exists on QoL for HD patients, particularly in Cyprus, necessitating further investigation to understand living conditions and improve management.
  • This study addresses the need for assessing QoL among Cypriot HD patients due to the disease's severity and prevalence.

Purpose of the Study:

  • To evaluate the health-related quality of life (QoL) in patients diagnosed with Huntington's disease (HD) residing in Cyprus.
  • To identify specific domains of QoL most affected by Huntington's disease in the Cypriot patient population.
  • To explore potential determinants, such as age at onset and disease duration, influencing QoL in this cohort.

Main Methods:

  • A cross-sectional study design was employed to assess QoL.
  • The standardized EQ-5D health-related QoL questionnaire was administered to 34 Huntington's disease patients in Cyprus.
  • This sample represented 46% of the total known HD patient population in Cyprus.

Main Results:

  • Self-care and performance of usual activities were the most severely impacted QoL domains (37.5% and 40.6% reporting severe problems, respectively).
  • Mobility and psychosocial well-being were also significantly affected, with 25.0% and 15.6% reporting severe problems, respectively.
  • Age at onset and disease duration were identified as significant determinants impacting mobility, self-care, and usual activities, as well as the overall QoL score.

Conclusions:

  • Age at onset and disease duration critically influence the QoL of Cypriot Huntington's disease patients, particularly affecting mobility and daily functioning.
  • A notable percentage of patients reported 'Some Problems' in the Pain/Discomfort category, possibly due to questionnaire translation issues, highlighting the need for culturally adapted instruments.
  • The significant psychosocial burden, even on asymptomatic patients, requires targeted acknowledgment and management strategies to enhance overall QoL.
Abstract